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Abstract
Background: Plants have long served as a rich source of drugs. Given some microorganisms’ acquisition of resistance to the current
antibiotics, there is a need for discovering new drugs.
Objectives: The aim of the present study was to investigate the phytochemical properties and antibacterial effects of Salvia multi-
caulis Vahl., Euphorbia microsciadia Boiss., and Reseda lutea against Acinetobacter baumanii and Staphylococcus aureus.
Methods: In this experimental study, hydroalcoholic (ethanol 70%) plant extracts were prepared by maceration. Minimum in-
hibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) were determined by CLSI broth microdilution
and Müller-Hinton agar assay for each sample, respectively. Total phenolic content was measured by Folin-Ciocalteu colorimetric
assay and expressed in terms of gallic acid equivalent and total flavonoid content by aluminum chloride colorimetric method and
in terms of rutin equivalent.
Results: Findings showed that 1, 4, and 1 mg/mL were derived as MICs and 4, 16, and 8 mg/mL as MBCs for S. multicaulis Vahl., E.
microsciadia Boiss., and R. lutea, respectively, against S. aureus; 2, 8, and 2 mg/mL were derived as MICs and 16, 32, and 16 mg/mL as
MBCs for S. multicaulis Vahl. R. lutea, and E. microsciadia Boiss., respectively, against A. baumanii. In addition, E. microsciadia Boiss. and
S. multicaulis Vahl. were found to contain the highest total phenolic and flavonoid content, respectively.
Conclusions: The studied plants that were collected from Chaharmahal and Bakhtiari Province can be used to produce antibiotics
due to their phenols and flavonoids and exert antibacterial effects on the studied bacteria.
Keywords: Medicinal Plants, Drug Resistance, Minimum Inhibitory Concentration, Minimum Bactericidal Concentration,
Phytochemistry
1. Background
Evidence indicates that the antibiotic resistance of bac-
teria has increased (1). Acinetobacter baumanii and Staphy-
lococcus aureus are two particularly ubiquitous bacteria. A.
baumanii is a Gram-negative and non-glucose fermenting
coccobacillus that is one of the main common causes of
nosocomial infections because of high levels of drug resis-
tance (2). In Chile, Carbapenem resistance of A. baumanii
in the ICU was reported to be up to 70% (3). A study in 2012
showed that the resistance of A. baumanii to Imipenem
and Meropenem in the ICU-admitted patients was 76%
and 80.2%, respectively (4). A study in Ohio, USA showed
that the mortality was 70% because of resistant A. bau-
manii infection and the mortality only 25% because of non-
resistant A. baumanii infection (5). Moreover, Staphylococ-
cus aureus is one of the life-threatening pathogens for the
human that can cause a wide spectrum of diseases, rang-
ing from skin infections to respiratory and urinary tract in-
fections. This bacterium can cause certain life-threatening
diseases such as endocarditis, toxic shock syndrome toxin,
and osteomyelitis (6). Asia is addressed as one of the re-
gions with the highest prevalence of methicillin-resistant
S. aureus (MRSA) worldwide, and vancomycin-resistant S.
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aureus strains have been reported in certain Asian coun-
tries as well (7). The latest findings have shown that the
prevalence of MRSA is 73% of the clinical samples collected
from the hospitals in Taiwan (8).
Given the reported extensive drug resistance, there is
a need for developing and using new antibacterial drugs
that do not lead to drug resistance and also have efficient
therapeutic effects. In this regard, the use of medicinal
plants is an approach to discover new drugs (9-11). In ad-
dition, the medicinal plants that are collected from the re-
gions with different climates may have different amounts
of active compounds and exert biological activities of dif-
ferent degrees (12,13). In this regard, the aim of this study
was to investigate the phytochemical properties and an-
tibacterial effects of Salvia multicaulis Vahl., Euphorbia mi-
crosciadia Boiss., and Reseda lutea, collected from Cha-
harmahal and Bakhtiari province, against A. baumanii and
S. aureus.
To date, 1000 plant species from the Salvia genus of
the subfamily Nepetoideae and the family Lamiaceae have
been identified, of which 56 are native to Iran (14). Salvia
multicaulisVahl. grows mainly in Central and East Asia (15).
The main compounds of this plant include 1,8-cineole, α-
pinene, and camphor (16). The pharmaceutical effects of
this plant include anti-inflammatory, antimicrobial, and
analgesic effects (15). Euphorbia microsciadia Boiss is from
the family of Euphorbiacea that is one of the largest fam-
ilies of flowering plants, including over 300 genera and
5000 species (17). In relevant textbooks, E. microsciadia has
been reported to have anti-anxiety, analgesic, antipyretic,
and antimicrobial effects (18). Reseda lutea L., also known
as Reseda vulgaris, is a member of the family Resedaceae
(19). R. lutea has been reported to have cytotoxic, antitu-
mor, anti-HIV, antibacterial, and anti-inflammatory effects
(19, 20). This plant contains benzyl isothiocyanate and 2-
(α-L-rhamnopyranosyloxy) benzyl isothiocyanate that has
cytotoxic effects (19).
2. Methods
2.1. Collecting Plants
The plants (E. microsciadia, S. multicaulis Vahl. and
R. lutea) were collected from different regions of Cha-
harmahal and Bakhtiari Province (in Iran) such as Saman,
Shahrekord, and Teshniz between late March 2016 and late
September 2016 and then identified as the plants of inter-
est by a botanist (Dr. Shirmardi) at the Research Center of
the Agricultural Jihad Organization of Chaharmahal and
Bakhtiari province.
2.2. Extraction
Extraction was conducted by maceration of the aerial
parts of E. microsciadia and S. multicaulis Vahl. and the seeds
of R. lutea in triplicate (each time for 72 hours). In this
method, water and butyric acid-free bitter ethanol at 30/70
ratio were used (ethanol 70%). The resulting extract was
filtered using a filter paper and evaporated under next-to-
vacuum pressure and 40°C by a rotary evaporator to con-
centrate. The resulting solution was stored at -20°C until
later use.
2.3. Preparing Different Dilutions of Extract
Ninety-six mg of each extract was weighed using a digi-
tal scale and stock solutions of the extracts prepared using
dimethyl sulfoxide (DMSO; Sigma, USA) and distilled water.
Then different dilutions (0.25, 0.5, 1, 2, 4, 8, and 16 mg/mL)
of the extracts were prepared using Mueller-Hinton agar.
The maximum concentration of DMSO was 0.2% in the fi-
nal concentration (21, 22).
2.4. Preparing Standard Bacterial Strains
S. aureus strain (ATCC 12923) and A. baumanii strain
(PTCC 1855) were purchased as lyophilized from Iranian Re-
search Organization for Science and Technology.
2.5. Preparing Microbial Suspension
To prepare a microbial suspension equivalent to 0.5
McFarland standard (1.5× 108 CFU/mL), a 24-hour culture
of the bacteria was performed on blood agar, and then a
suspension with 0.5 McFarland turbidity prepared in nor-
mal saline.
2.6. Determining Minimum Inhibitory Concentrations (MICs)
and Minimum Bactericidal Concentrations (MBCs)
The antimicrobial effects of the extracts were deter-
mined by broth microdilution in a sterile 96-well plate
(SPL life science; Korea) with reference to 0.5 McFarland
standard (1.5 × 108 CFU/mL). In this method, the first
well was considered negative control (culture medium +
the extract) and the second well positive control (culture
medium + the bacterium). After adding 95 µL culture
medium and 100µL extracts to microplate wells and dilut-
ing them, we incubated the samples at 37°C for 24 hours.
The concentration of the last (most diluted) well without
turbidity was considered MIC (23). To determine MBC, we
subsequently performed a culture of the samples of each
well at 10 µL on Mueller-Hinton agar and incubated them
at 37°C for 24 hours. The lowest concentrations of the ex-
tract in which the bacteria could not grow were considered
MBCs. The tests to determine the MICs and MBCs were con-
ducted in triplicate (24).
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2.7. Determining Total Phenolic and Flavonoid Content
Total phenolic content was measured by Folin-
Ciocalteu colorimetric assay and expressed in terms
of gallic acid equivalent and total flavonoid content by
aluminum chloride colorimetric method and in terms of
rutin equivalent (25-27).
For total phenolic content, 0.1 mL of extract was trans-
ferred to a test tube, and 0.5 mL of Folin-Ciocalteu reagent
was added and mixed gently. After 5 minutes incubation,
0.4 mL of 7.5% (w/v) sodium carbonate was added to the
mixture. The mixture was allowed to stand at room tem-
perature for 30 minutes. UV-vis absorption measurements
were carried out at 765 nm using a spectrophotometer
(UNICO 2100: USA). The standard calibration curve was
plotted using gallic acid in methanol. The TPC was ex-
pressed as gallic acid equivalents (mg GAE/g dry weight of
the extract).
For flavonoid content, 0.5 mL of the extract was trans-
ferred to a test tube and mixed with 1.5 mL of methanol.
Then 0.5 mL of 2% aluminum chloride (AlCl3) and 3 mL
of 5% potassium acetate were added to the extract. After
40 minutes incubation, UV-vis absorption measurements
were carried out at 415 nm using a spectrophotometer
(UNICO 2100: USA). The standard calibration curve was
plotted using rutin in methanol.
4. Results
The S. aureus was susceptible to S. multicaulis and in-
hibited at 1 mg/mL, but was resistant to 0.5 mg/mL of this
extract. Therefore, the most acceptable MIC of this plant
against S. aureus was determined 1 mg/mL. On the other
hand, this bacterium was completely eliminated by S. mul-
ticaulis and could not grow at 4 mg/mL concentration.
Therefore, the MBC of this plant against S. aureus was deter-
mined 4 mg/mL. The results on the antimicrobial effect of
hydroalcoholic S. multicaulis extract on A. baumanii showed
that this extract at 2 mg/mL could inhibit this bacterium,
with 16 mg/mL determined as its MBC for A. baumanii. Fur-
thermore, the MIC and MBC of E. microsciadia for S. aureus
were determined 4 mg/mL and 16 mg/mL, respectively, and
the MIC and MBC of this plant for A. baumanii 8 mg/mL and
32 mg/mL, respectively; the MIC and MBC of R. lutea for S. au-
reus were determined 1 mg/mL and 2 mg/mL, respectively,
and the MIC and MBC of this plant for A. baumanii 8 mg/mL
and 32 mg/mL, respectively (Tables 1 and 2).
According to Table 3, all three plants contained phenols
and flavonoids. E. microsciadia and S. multicaulis contained
the highest total phenolic and flavonoid contents, respec-
tively (Table 3).
5. Discussion
This study was conducted to investigate the phy-
tochemical properties and antibacterial effects of
S.multicaulis, E. microsciadia, and R. lutea against A.
baumanii and S. aureus, showing that these plants can be
considered alternatives for developing new antibiotics
against some microorganisms that are resistant to routine
drugs, owing to phenols and flavonoids and exerting
antibacterial effects.
Our results showed that S. multicaulis could exert in-
hibitory and bactericidal effects on both S. aureus and A.
baumanii but these effects on S. aureus were more potent.
The flavonoid content of this plant was also higher than
the other two plants. The study of Akin et al. to investigate
the antimicrobial effects of Salvia cryptantha and Salvia hel-
dreichiana, revealed that these two species did not exert
any inhibitory effect on S. aureus (28). Inconsistently, our
study with S. multicaulis showed that this plant exerted a
potent inhibitory effect on this bacterium. The study of
Alim et al. indicated that methanol Salvia cedronella ex-
tract had inhibitory effects on S. aureus and B. cereus, with
an MIC of 31.25 µg/mL, which is in agreement with our
study. Alim et al. attributed their observations about the
inhibitory properties to the high concentrations of phe-
nols and flavonoids in S. cedronella (29). Fazly Bazzaz et
al. reported that Salvia chloroleuca exerted a partial in-
hibitory effect on S. aureus, while Salvia ceratophylla, Salvia
lourifolia, Salvia limbata, and Salvia macrosiphone had no in-
hibitory effect on this bacterium (30).
Our results were promising regarding the antimicro-
bial effects of E. microsciadia to inhibit S. aureus and A.
baumanii thus its MIC and MBC for S. aureus were de-
termined 4 mg/mL and 16 mg/mL and for A. baumanii 8
mg/mL and 32 mg/mL, respectively. Also, E. microsciadia
contained comparatively higher concentrations of phe-
nols and flavonoids. The study of Eshraghi et al. investi-
gated the effects of 10 plant species on the Nocardia genus,
showed that Euphorbia denticulate could inhibit the growth
of Nocardia asteroides and Nocardia brasiliensis (31). Kaveh et
al. observed that the species of Euphorbia were rich sources
of flavonoids, and E. microsciadia contained abundant phe-
nols such as kaempferol (32).
Moreover, R. lutea was found to exert antimicrobial ef-
fects on S. aureus and A. baumanii. This plant was also
found to contain phenols and flavonoids. The study of
Boroumand et al. showed that R. lutea-assisted synthesis
of silver nanoparticles led to the inhibition of Escherichia
coli in vitro (33). Benmerache et al. reported that chloro-
form Reseda phyteuma L. extract had inhibitory effects on
S. aureus, Proteus mirabilis, and Pseudomonas aeruginosa so
that its MIC for all three bacteria was 80 µg/mL and the
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Table 1. The Minimum Inhibitory Concentrations and Minimum Bactericidal Concentrations of the Hydroalcoholic Extracts of Studied Plants for Staphylococcus aureus
Plants, Effect
Concentration (mg/mL)a
0.25 0.5 1 2 4 8 16 32
Salviamulticaulis Vahlb
MIC - - + + + + + +
MBC - - - - + + + +
Euphorbiamicrosciadia Boiss.b
MIC - - - - + + + +
MBC - - - - - - + +
Reseda luteac
MIC - - + + + + + +
MBC - - - - - + + +
a(+), Lack of microorganism growth in culture medium and the antimicrobial activity of the hydroalcoholic (ethanol 70%) extracts of plants; (-), Microorganism growth
in culture medium and lack of antimicrobial activity of the hydroalcoholic extracts of plants.
bThe extraction of aerial parts.
cThe extraction of seeds.
Table 2. The Minimum Inhibitory Concentrations and Minimum Bactericidal Concentrations of the Hydroalcoholic Extracts of Studied Plants for Acinetobacter baumanii
Plants, Effect
Concentration (mg/mL)a
0.25 0.5 1 2 4 8 16 32
Salviamulticaulis Vahlb
MIC - - - + + + + +
MBC - - - - + - + +
Euphorbiamicrosciadia Boiss.b
MIC - - - - + + + +
MBC - - - - - - - +
Reseda luteac
MIC - - - + + + + +
MBC - - - - - - + +
a(+), Lack of microorganism growth in culture medium and the antimicrobial activity of the hydroalcoholic (ethanol 70%) extracts of plants; (-), Microorganism growth
in culture medium and lack of antimicrobial activity of the hydroalcoholic extracts of plants.
bThe extraction of aerial parts.
cThe extraction of seeds.
Table 3. Total Phenolic and Flavonoid Content of the Studied Plantsa
Plants Used Organ Total Phenolic Content mg GAE/g DW Flavonoid Content mg RU/g DW
Euphorbiamicrosciadia Boiss Shoot 69.56± 6.75 24.39± 1.38
SalviamulticaulisVahl. Shoot 63.96± 5.11 26.74± 2.24
Reseda lutea L. Seeds 65.32± 3.72 21.93± 2.67
aValues are expressed as mean± SD.
inhibition zone diameters for P. mirabilis, S. aureus, and P.
aeruginosa were 13 mm, 12 mm, and 11 mm, respectively
(34), while the study of Yildirim et al. in Turkey showed
that R. lutea showed no antimicrobial effect on S. aureus.
That study also demonstrated that this plant could not ex-
ert any antimicrobial effect on Staphylococcus epidermidis,
Streptococcus pyogenes, Serratia marcescens, Salmonella ty-
phimurium, P. aeruginosa, Proteus vulgaris, and E. coli, mean-
while had a partial inhibitory effect on Klebsiella pneumo-
niae (35).
The concentrations of bioactive compounds in a
medicinal plant may vary and, therefore, exhibit various
biological effects depending on the location and time of its
collection as well as its part of use (12,13). The inconsistency
in the findings of our study and others’ can be attributed
to different concentrations of the bioactive compounds
due to the difference in the occurrence locations of the
studied plants as well as their parts of use. The plants
that were investigated in the current study and collected
from Chaharmahal and Bakhtiari province could pave
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the way for producing antibiotics due to their phenols
and flavonoids and exerting antibacterial effects on the
studied bacteria.
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